Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Second interim dividend

27 Jun 2025 17:57

RNS Number : 8462O
Experian plc
27 June 2025
 

Experian plc

 

 

Second interim dividend - exchange rate and Irish dividend withholding tax

 

 

27 June 2025 - Experian plc, the global data and technology company, hereby notifies the market that, further to the announcement on 14 May 2025 of a second interim dividend of 43.25 US cents per ordinary share payable on 18 July 2025 to shareholders on the register of members at the close of business on 20 June 2025, the exchange rate to be used to convert the dividend payment from US dollars to sterling pounds, for those shareholders who did not elect by 20 June 2025 to receive payment in US dollars, will be £1 = $1.37168. Accordingly, the sterling amount of dividend payable on 18 July 2025 to such shareholders will be approximately 31.5306 pence per share.

 

Shareholders who did not elect to receive UK sourced dividends through the income access share arrangements are reminded that, as previously advised, their dividends will be subject to Irish dividend withholding tax unless the Company's Registrars are in possession of a valid exemption form. As previously advised, the final date for submission of elections to receive UK sourced dividends via the income access share arrangements was 20 June 2025. In the absence of any such elections, previous elections or deemed elections will remain in force.

 

Contact:

 

Experian

Claire Murphy

Deputy Company Secretary

+353 (0) 87 421 3311

 

 

About Experian

 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

 

Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVQDLFLEQLEBBQ
Date   Source Headline
15th Jun 20225:36 pmRNSTransaction in Own Shares
15th Jun 202210:00 amRNSDirector/PDMR Shareholding
10th Jun 20223:39 pmRNSAnnual Financial Report
10th Jun 202210:00 amRNSElections for second interim dividend
9th Jun 20224:15 pmRNSDirector/PDMR Shareholding
31st May 202211:42 amRNSTotal Voting Rights
26th May 20225:08 pmRNSTransaction in Own Shares
25th May 20225:43 pmRNSTransaction in Own Shares
24th May 20225:22 pmRNSTransaction in Own Shares
23rd May 20225:41 pmRNSTransaction in Own Shares
20th May 20225:35 pmRNSTransaction in Own Shares
19th May 20225:38 pmRNSTransaction in Own Shares
18th May 20226:15 pmRNSTransaction in Own Shares
18th May 202211:30 amRNSShare repurchases
18th May 20227:00 amRNSFull-year financial report
16th May 20227:00 amRNSExperian agrees to acquire majority stake in MOVA
29th Apr 202212:01 pmRNSTotal Voting Rights
6th Apr 20229:35 amRNSAdditional Listing
31st Mar 20221:35 pmRNSTotal Voting Rights
30th Mar 20229:15 amRNSAdditional Listing
23rd Mar 20229:33 amRNSAdditional Listing
16th Mar 20229:30 amRNSBlock listing Interim Review
9th Mar 20224:41 pmRNSSecond Price Monitoring Extn
9th Mar 20224:37 pmRNSPrice Monitoring Extension
2nd Mar 20229:15 amRNSAdditional Listing
28th Feb 20222:07 pmRNSTotal Voting Rights
23rd Feb 20229:15 amRNSAdditional Listing
10th Feb 20224:45 pmRNSBond issue
10th Feb 20229:20 amRNSAdditional Listing
2nd Feb 20229:15 amRNSAdditional Listing
1st Feb 20225:56 pmRNSTransaction in Own Shares
31st Jan 202210:12 amRNSTotal Voting Rights
26th Jan 20222:04 pmRNSAdditional Listing
20th Jan 20225:45 pmRNSTransaction in Own Shares
19th Jan 202211:31 amRNSAdditional Listing
19th Jan 20227:00 amRNSDirectorate Changes
14th Jan 20225:53 pmRNSFirst interim dividend
14th Jan 20227:00 amRNSExperian Q3 FY22 trading update
11th Jan 20226:05 pmRNSTransaction in Own Shares
10th Jan 20225:54 pmRNSTransaction in Own Shares
7th Jan 20226:08 pmRNSTransaction in Own Shares
6th Jan 20226:17 pmRNSTransaction in Own Shares
31st Dec 202112:15 pmRNSTotal Voting Rights
31st Dec 20219:30 amRNSElections for first interim dividend
30th Dec 20213:26 pmRNSShare repurchases
15th Dec 20219:42 amRNSAdditional Listing
1st Dec 20219:15 amRNSAdditional Listing
30th Nov 20219:45 amRNSTotal Voting Rights
26th Nov 20213:27 pmRNSDirector/PDMR Shareholding
24th Nov 20219:15 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.